- Fertilite Contraception
- Published:
Traitements anticancereux et spermatogenese. Moyens de protection
Antineoplasic treatments and spermatogenesis. Means of protection
Andrologie volume 2, pages 97–99 (1992)
Abstract
A litterature review reports the spermatotoxicity of the different antineoplasic therapies. Recovery of spermatogenesis after completion of most toxic treatments and its delay are individually unforeseen. Pregnancies have occured after treatment with very low sperm counts. These pregnancies ask the question of mutagenicity of antineoplasic treatments. The means of protection seem presently very poor.
Resume
Une revue de la littérature fait le point de la spermatotoxicité des différentes thérapeutiques anticancéreuses. Après les traitements réputés stérilisants, la récupération de la fonction gamétogénétique et son délai s’avèrent imprévisibles au plan individuel. Des grossesses ont été obtenues après traitement anticancéreux avec des chiffres de numération spermatique très bas. Celles-ci posent le problème de la mutagénicité des thérapeutiques anticancéreuses. Les moyens de protection s’avèrent actuellement limités.
References
- Bonnadonna G., Santoro A., Viviani S., Lombardi C., Ragni G. Gonadal damage in Hodgkin’s disease from cancer chemotherapeutic regimens. Arch. Toxicol., 1984,sup7:140
- Chapman R.M., Sutcliffe S.B., Rees L.H., Edwards C.R.W., Malpas J.S. Cyclical combination chemotherapy and gonadal function. Lancet, 1979,i:285
- Chapman R.M., Sutcliffe S.B., Crosby W.H. Reproductive potential after treatment for Hodgkin’s disease. N.Eng.J.Med., 1981,305:890
- Da Cuhna M.F., Meistrich M.L., Fuller L.M., Cundiff J.H., Hagemeister F.B., Velasquez W.S., Mc Laughlin P., Riggs S.A., Cabanillas F.F., Salvador P.G. Recovery of spermatogenesis after treatment for Hodgkin’s disease: limiting dose of Mopp chemotherapy. J.Clin.Oncol., 1984,2:571.
- Damewwod M.D., Grochow L.B. Prospects for fertility after chemotherapy or radiation for neoplastic disease. Fertil.Steril., 1986,4:443
- Friedmann N.M., Plymate S.R. Leydig cell dysfunction and gynecomastia in adult males treated with alkylating agents. Clin.Endoc., 1980, 12:553
- Glode L.M., Robinson J., Gould S.F. Protection from cyclophosphamide induced testicular damage with an analog of gonadotrophin releasing hormone. Lancet, 1981,i:1132
- Hahn E.W., Feingold S.M., Niscel L. Aspermia and recovery of spermatogenesis in cancer patients following incidental gonadal irradiation during treatment: a progress report. Radiology 1976,119:223
- Hahn E.W., Feingold S.M., Simpson L., Batata M. Recovery from aspermia induced by low dose radiation in seminoma patients. Cancer, 1982,50:337
- Hsu E.W., Folami A.O., Bain J., Rance C.P. Gonadal function in males treated with cyclophosphamide for neoplastic syndrome. Fertil.Steril. 1979,31:173
- Jackson H., Hass C.A., Sooby D., Marschke C.H. The gonadal exposure of boys and young men treated with inverted Y fields. Radiology 1970,96:181
- Kreuser E.D., Hetzel W.D., Heit W., Hoelzer D., Eurrle E., Xiros N., Heimpel H. Reproductive and endocrine function gonadal functions in adults following multidrug chemotherapy for acute lymphoblastic or undifferentiated leukemia. J.Clin.Oncol., 1988,6:588
- Marmor D. Influence de la maladie de Hodgkin sur les fonctions reproductrices. In: Progrès en Hématologie. Hoerni B., Simon G, Gisselbrech C. ed. Doin Paris, 1985: 165
- Meistrich M.L. Relationship between spermatogonial stem cell survival and testis function after cytotoxic therapy. Br.J.Cancer, 1986,53:89
- Morris I.D., Shalet S.M. Protection of gonadal function from cytotoxic chemotherapy and irradiation. Baill.Clin.Endoc.Metab., 1990,4:97
- Pontonnier S., Navratil H. Stérilité masculine et cancer du testicule. J.Urol., 1984,90:308
- Richter P., Calamera J.C., Morgenfield M.C., Kierszenbaum A.L., Lavieri J.C., Mancini R.E. Effects of chlorambucil on spermatogenesis in the human with malignant lymphoma. Cancer, 1970,25:1026
- Rowley M.J., Leach D.R., Warner G.A., Heller C.G. Effects of graded doses of ionizing radiations on the human testis. Radiat.Res., 1974,59:665
- Sandeman T.F. The effects of X irradiation on the human fertility. Brit.J.Radiol., 1966,39:901
- Schweiguth O. L’avenir des enfants guéris d’un cancer. Arch.Fr.Pediatr., 1985,42:3
- Sherins R.J., Olweny C.L.M., Ziegler J.L. Gynaecomastia and gonadal dysfunction in adolescent boys treated with combination chem therapy for Hodgkin’s disease. N.Engl.J.Med., 1978,299:12
- Withehead E., Shalet S.M., Blckledge G., Tood L., Crowther D., Beardwell C.G. The effects of Hodgkin’s disease and combination chemotherapy on gonadal function in the adult male. Cancer 1982,49:418
Author information
Authors and Affiliations
Additional information
présenté aux 4èmes Journées d’Andrologie de l’Hôpital Saint-Antoine le 15 Juin 1992
Rights and permissions
About this article
Cite this article
Grob-Menendez, F., Marmor, D. Traitements anticancereux et spermatogenese. Moyens de protection. Androl. 2, 97–99 (1992). https://doi.org/10.1007/BF03034683
Issue Date:
DOI: https://doi.org/10.1007/BF03034683